New issues raised in the Generic licensing industry are going to be the center of attention at Fleming Europe's upcoming conference. Opportunities in emerging markets of BRIC countries and development in the EU will dominate the discussions held in Berlin. The current situation in the pharmaceutical industry is turning ...

Oseltamivir. Esomeprazole. Trastuzumab. Where do drugs get those odd-sounding generic names? The answers are in the current issue of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society, which explains the logic behind the tongue-twisters.

(American Chemical Society) Oseltamivir. Esomeprazole. Trastuzumab. Where do drugs get those odd-sounding generic names? The answers are in the current issue of Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, the world's largest scientific society, which explains the logic behind the tongue-twisters.

Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.

The popular cholesterol-lowering drug Lipitor goes off-patent today. Manufacturer Pfizer planned ahead, making agreements with some insurers to keep covering the drug.

The US Food and Drug Administration (FDA) announced on Wednesday that it has approved the first generic version of the world's top-selling medicine, the cholesterol-lowering drug Lipitor (atorvastatin), currently marketed by Pfizer Inc. Ranbaxy Laboratories Limited, India's largest pharmaceutical company, has gained FDA approval to make generic ...

Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.

Watson Pharmaceuticals, Inc. today confirmed that Watson Pharmaceuticals, Inc., has launched an authorized generic version of LIPITOR (atorvastatin calcium tablets) as part of an exclusive agreement with Pfizer Inc.

The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor.

Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz oral contraceptive product.

Perrigo Company and its partner Synthon Pharmaceuticals, Inc. today announced that Perrigo has begun shipping Levocetirizine Solution, 2.5 mg/5ml, a generic version of UCB's Xyzal Oral Solution.